Dr. Owen Mogabgab, MD

Dr. Mogabgab practices at Cardiovascular Institute of the South in Harvey, Louisiana.

Dr. Mogabgab's NPI, 1669528915, was assigned on January 26, 2007. Dr. Mogabgab graduated from University of Texas Medical School at Houston in 2006. Dr. Mogabgab holds Louisiana license MD.206730.

Dr. Mogabgab's primary practice is Cardiovascular Institute of the South, at 1901 Manhattan Blvd, Harvey, LA 70058 in Jefferson Parish. The practice phone is (985) 876-0300.

Dr. Mogabgab's primary practice is Cardiovascular Institute of the South in Harvey, Louisiana. Dr. Mogabgab is also affiliated with Touro Infirmary. The medical group on file is Cardiovascular Institute of the South. Dmand AI also links Dr. Mogabgab to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mogabgab practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mogabgab's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Mogabgab's licenses on file in 3 states: Louisiana, Massachusetts and Texas.

CMS data shows 10,202 Medicare services from Dr. Mogabgab across 47 procedure codes in 2024, for 742 Medicare patients. Medicare paid $532,851 for them.

CMS counts 742 Medicare patients who saw Dr. Mogabgab in 2024. The largest group is 65 to 74, with 358 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mogabgab's median patient age at 68, with 50% women.

In 2024, Dr. Mogabgab wrote 17,145 Medicare Part D claims for 1,513 patients. 82% of them were for generic drugs. CMS names the drug for 16,750 of them, across 95 drugs with 11 or more claims each, at $2,794,761 in total drug cost. In 2023, CMS named 11,976 claims across 89 drugs.

Dr. Mogabgab accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mogabgab as offering telehealth. CMS counts 20 procedures of coronary angioplasty and stenting by Dr. Mogabgab, more than 50% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Mogabgab, published from 2012 to 2018. 2013 was the busiest year, with 7. The most frequent topics are Coronary Angiography, Percutaneous Coronary Intervention and Circadian Rhythm. Dr. Mogabgab has published most often in J Interv Cardiol. Dr. Mogabgab's most frequent co-authors are Subhash Banerjee, MD, Eric Fuh, MD and Shuaib Abdullah, MD.

CMS Open Payments shows 617 general payments to Dr. Mogabgab from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. AstraZeneca Pharmaceuticals LP paid the most, $18,323.

Dr. Mogabgab graduated from University of Texas Medical School at Houston in 2006.